Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists
VA · va-education · Published 2021-09-20 · Effective 2021-10-20 · 86 FR 52072
Document
Document number
2021-20196
Federal Register citation
86 FR 52072
CFR reference
38 CFR 17
Type
Rule
Action
Final rule.
Category
va-education
Agency
US Department of Veterans Affairs
Publication date
2021-09-20
Effective date
2021-10-20
Abstract
The Department of Veterans Affairs (VA) is amending its medical regulations that govern copayments to conform with recent statutory requirements. VA is eliminating the copayment requirement for opioid antagonists furnished to veterans who are at high risk of overdose of a specific medication or substance in order to reverse the effect of such an overdose. VA is also clarifying that no copayment is required for the provision of education on the use of opioid antagonists. This final rule is an essential part of VA's attempts to help veterans at high risk of overdose.